Northwestern Mutual Wealth Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
QCM
NAMA
Northwestern Mutual Wealth Management's TXG Position: Q2 2026 in Review
Northwestern Mutual Wealth Management increased its 10x Genomics (TXG) stake by 5.6% in Q2 2026, buying an estimated $1.28K and bringing the position to 921 shares worth $35.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2662.
Northwestern Mutual Wealth Management first reported a position in TXG in Q4 2020 and has held it in 20 quarters since. The position peaked at $43K in Q1 2024. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.
- Northwestern Mutual Wealth Management held 921 shares of 10x Genomics worth $35.3K as of Q2 2026.
- Northwestern Mutual Wealth Management bought 49 10x Genomics shares in Q2 2026, an estimated $1.28K.
- 10x Genomics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2662 holding.
- Northwestern Mutual Wealth Management first reported a position in 10x Genomics in Q4 2020 and has held it in 20 quarters since.
- Northwestern Mutual Wealth Management's 10x Genomics position peaked at $43K in Q1 2024.
- 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.